BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 15583747)

  • 1. A variant thrombasthenic phenotype associated with compound heterozygosity of integrin beta3-subunit: (Met124Val)beta3 alters the subunit dimerization rendering a decreased number of constitutive active alphaIIbbeta3 receptors.
    González-Manchón C; Butta N; Larrucea S; Arias-Salgado EG; Alonso S; López A; Parrilla R
    Thromb Haemost; 2004 Dec; 92(6):1377-86. PubMed ID: 15583747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A naturally occurring point mutation in the beta3 integrin MIDAS-like domain affects differently alphavbeta3 and alphaIIIbbeta3 receptor function.
    Morel-Kopp MC; Melchior C; Chen P; Ammerlaan W; Lecompte T; Kaplan C; Kieffer N
    Thromb Haemost; 2001 Dec; 86(6):1425-34. PubMed ID: 11776310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal cytoplasmic extensions associated with active αIIbβ3 are probably the cause for macrothrombocytopenia in Glanzmann thrombasthenia-like syndrome.
    Hauschner H; Mor-Cohen R; Messineo S; Mansour W; Seligsohn U; Savoia A; Rosenberg N
    Blood Coagul Fibrinolysis; 2015 Apr; 26(3):302-8. PubMed ID: 25806962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type I Glanzmann thrombasthenia caused by an apparently silent beta3 mutation that results in aberrant splicing and reduced beta3 mRNA.
    Xie J; Pabón D; Jayo A; Butta N; González-Manchón C
    Thromb Haemost; 2005 May; 93(5):897-903. PubMed ID: 15886806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A point mutation in the cysteine-rich domain of glycoprotein (GP) IIIa results in the expression of a GPIIb-IIIa (alphaIIbbeta3) integrin receptor locked in a high-affinity state and a Glanzmann thrombasthenia-like phenotype.
    Ruiz C; Liu CY; Sun QH; Sigaud-Fiks M; Fressinaud E; Muller JY; Nurden P; Nurden AT; Newman PJ; Valentin N
    Blood; 2001 Oct; 98(8):2432-41. PubMed ID: 11588040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A beta3 Asp217-->Val substitution in a patient with variant Glanzmann Thrombasthenia severely affects integrin alphaIIBbeta3 functions.
    D'Andrea G; Bafunno V; Del Vecchio L; Amoriello A; Morabito P; Vecchione G; Grandone E; Margaglione M
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):657-62. PubMed ID: 18832906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel 196Leu to Pro substitution in the beta3 subunit of the alphaIIbbeta3 integrin in a patient with a variant form of Glanzmann thrombasthenia.
    Nurden AT; Ruan J; Pasquet JM; Gauthier B; Combrié R; Kunicki T; Nurden P
    Platelets; 2002 Mar; 13(2):101-11. PubMed ID: 11897046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel homozygous mutation (1619delC) in GPIIb gene associated with Glanzmann thrombasthenia, the decay of GPIIb-mRNA and the synthesis of a truncated GPIIb unable to form complex with GPIIIa.
    Losonczy G; Rosenberg N; Kiss C; Kappelmayer J; Vereb G; Kerényi A; Balogh I; Muszbek L
    Thromb Haemost; 2005 May; 93(5):904-9. PubMed ID: 15886807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double heterozygosity for a novel missense mutation of Ile304 to Asn in addition to the missense mutation His280 to Pro in the integrin beta3 gene as a cause of the absence of platelet alphaIIbbeta3 in Glanzmann's thrombasthenia.
    Tanaka S; Hayashi T; Yoshimura K; Nakayama M; Fujita T; Amano T; Tani Y
    J Thromb Haemost; 2005 Jan; 3(1):68-73. PubMed ID: 15634267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel S527F mutation in the integrin beta3 chain induces a high affinity alphaIIbbeta3 receptor by hindering adoption of the bent conformation.
    Vanhoorelbeke K; De Meyer SF; Pareyn I; Melchior C; Plançon S; Margue C; Pradier O; Fondu P; Kieffer N; Springer TA; Deckmyn H
    J Biol Chem; 2009 May; 284(22):14914-20. PubMed ID: 19329429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A naturally occurring mutation near the amino terminus of alphaIIb defines a new region involved in ligand binding to alphaIIbbeta3.
    Basani RB; French DL; Vilaire G; Brown DL; Chen F; Coller BS; Derrick JM; Gartner TK; Bennett JS; Poncz M
    Blood; 2000 Jan; 95(1):180-8. PubMed ID: 10607701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunisation against αIIbβ3 and αvβ3 in a type 1 variant of Glanzmann's thrombasthenia caused by a missense mutation Gly540Asp on β3.
    Wihadmadyatami H; Röder L; Berghöfer H; Bein G; Heidinger K; Sachs UJ; Santoso S
    Thromb Haemost; 2016 Aug; 116(2):262-71. PubMed ID: 27098940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoprotein IIb Leu214Pro mutation produces glanzmann thrombasthenia with both quantitative and qualitative abnormalities in GPIIb/IIIa.
    Grimaldi CM; Chen F; Wu C; Weiss HJ; Coller BS; French DL
    Blood; 1998 Mar; 91(5):1562-71. PubMed ID: 9473221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AlphaIIbG236E causes Glanzmann thrombasthenia by impairing association with beta3.
    Afrasiabi A; Gelain F; Artoni A; Mannucci PM
    Platelets; 2008 Aug; 19(5):322-7. PubMed ID: 18791937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A two-amino acid insertion in the Cys146- Cys167 loop of the alphaIIb subunit is associated with a variant of Glanzmann thrombasthenia. Critical role of Asp163 in ligand binding.
    Honda S; Tomiyama Y; Shiraga M; Tadokoro S; Takamatsu J; Saito H; Kurata Y; Matsuzawa Y
    J Clin Invest; 1998 Sep; 102(6):1183-92. PubMed ID: 9739052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel Pro126His beta propeller mutation in integrin alphaIIb causes Glanzmann thrombasthenia by impairing progression of pro-alphaIIbbeta3 from endoplasmic reticulum to Golgi.
    Shen WZ; Ding QL; Jin PP; Wang XF; Jiang YZ; Li SM; Wang HL
    Blood Cells Mol Dis; 2009; 42(1):44-50. PubMed ID: 18976939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 1063G-->A mutation in exon 12 of glycoprotein (GP)IIb associated with a thrombasthenic phenotype: mutation analysis of [324E]GPIIb.
    Tao J; Arias-Salgado EG; González-Manchón C; Iruín G; Butta N; Ayuso MS; Parrilla R
    Br J Haematol; 2000 Dec; 111(3):965-73. PubMed ID: 11122161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Ser752-->Pro substitution in the cytoplasmic domain of beta3 in a Glanzmann thrombasthenia variant fails to prevent interactions between the alphaIIbbeta3 integrin and the platelet granule pool of fibrinogen.
    Nurden P; Poujol C; Winckler J; Combrié R; Caen JP; Nurden AT
    Br J Haematol; 2002 Sep; 118(4):1143-51. PubMed ID: 12199799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Effect of the Mutations Similar to the Cleavage during Platelet Activation at Integrin β3 Cytoplasmic Tail when Expressed in Mouse Platelets.
    Shi X; Yang J; Cui X; Huang J; Long Z; Zhou Y; Liu P; Tao L; Ruan Z; Xiao B; Zhang W; Li D; Dai K; Mao J; Xi X
    PLoS One; 2016; 11(11):e0166136. PubMed ID: 27851790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical residues of integrin alphaIIb subunit for binding of alphaIIbbeta3 (glycoprotein IIb-IIIa) to fibrinogen and ligand-mimetic antibodies (PAC-1, OP-G2, and LJ-CP3).
    Kamata T; Irie A; Tokuhira M; Takada Y
    J Biol Chem; 1996 Aug; 271(31):18610-5. PubMed ID: 8702512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.